About SafeOp
SafeOp is a Healthcare company based in Hunt Valley (United States) founded in 2011, and was acquired by ATEC Spine in March 2018. Neuromonitoring devices for surgical nerve damage detection are developed. SafeOp has raised $10.91 million across 4 funding rounds from investors including ATEC Spine. Its focus areas include Life Sciences, Neurology, Medical Devices and Screening Devices. Its competitors include Rhaeos, Jan Medical and Branchpoint Technologies; 3 of its 3 listed competitors have raised funding.
Company details
SafeOp Surgical was founded in 2011 and is based in Hunt Valley, United States. Operations focus on the medical device sector, where the EPAD neuromonitoring device has been developed. FDA clearance has been obtained for the device, which is used to record somatosensory evoked potentials or assess the neuromuscular junction. Nerve damage is detected during procedures, and postoperative residual paralysis is evaluated through these monitoring functions.
- Headquarters Hunt Valley, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website safeop.net
- Acquired by ATEC Spine (Mar 2018)
- Total Equity Funding$10.91M (USD)
in 4 rounds
- Latest Funding Round$5.65M (USD), Series A
Jan 2018
- Investors
- Acquired byATEC Spine
(Mar 2018)
Funding Insights of SafeOp
SafeOp has successfully raised a total of $10.91M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $5.65 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.91M
- Total Rounds 4
- Last Round Series A — $5.65M
- First Round $1.14M
(Jan 2012)
All 4 funding rounds of SafeOp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $5.65M | Series A | – | – | – |
| Apr 2016 | $1.75M | Seed | – | – | – |
| Jul 2014 | $2.37M | Seed | – | – | – |
| Jan 2012 | $1.14M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in SafeOp
SafeOp has secured backing from 1 investor. Prominent investors backing the company include ATEC Spine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Treatment solutions for spine disorders are developed. | 1990 | atecspine.com | San Diego, United States |
Investor details for SafeOp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SafeOp
4 dated milestones of SafeOp across 7 years, from founding to its latest funding, stage changes and deals.
- Founded SafeOp is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A, of $5.7M.
- Exit Acquired by ATEC Spine.
Competitors of SafeOp
SafeOp has 3 listed competitors in our database, 3 of them funded. They include Rhaeos, Jan Medical and Branchpoint Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rhaeos.com | 2018 | Evanston, United States | $12.8M | 10 | Noninvasive device developed for CSF monitoring and hydrocephalus management. | |
| janmedical.com | 2003 | Mountain View, United States | $10.97M | 3 | Brain-sensing diagnostic devices for neurological conditions are provided. | |
| branchpointtechnologies.com | 2011 | San Clemente, United States | $3.98M | Intracranial pressure monitored via mobile app for brain injury patients. |
Detailed competitors of SafeOp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as SafeOp (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SafeOp
SafeOp was founded in 2011 and raised its 1st funding round 1 year after it was founded.
SafeOp is headquartered in Hunt Valley, United States. It is registered at Hunt Valley, Maryland, United States.
SafeOp is a funded company, having raised a total of $10.91M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.14M, raised on Jan 2012.
SafeOp Surgical was founded in 2011 and is based in Hunt Valley, United States. Operations focus on the medical device sector, where the EPAD neuromonitoring device has been developed. FDA clearance has been obtained for the device, which is used to record somatosensory evoked potentials or assess the neuromuscular junction. Nerve damage is detected during procedures, and postoperative residual paralysis is evaluated through these monitoring functions.
SafeOp's top competitors include Rhaeos, Jan Medical and Branchpoint Technologies.
SafeOp has 1 investor. Key investors include ATEC Spine.
Yes. SafeOp was acquired by ATEC Spine in March 2018.